Johnny
What results are you expecting ???
Each of those phase 1 or 2 collaborations have years to complete trials - refer each institutions website and see all trial information and completion dates
The current phase 11a trial - expects some results on safety - efficacy in late 2019
Some updates on dosages phase 11a have already been released this year
Then if all goes well with safety - will enter a phase 11b - dosage range trial by mid next year - estimated cost of $15m-$20m dollars alone
Cantrixil phase 1 results expected and Edison States they expect a partner to progress to phase 2 -if results merit this
DYOR outside of HC
- Forums
- ASX - By Stock
- KZA
- GDC--0084
GDC--0084, page-39
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online